{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:01:00Z","timestamp":1778590860533,"version":"3.51.4"},"reference-count":26,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.3892\/or.2015.4324","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T08:54:51Z","timestamp":1443776091000},"page":"3187-3195","source":"Crossref","is-referenced-by-count":15,"title":["Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells"],"prefix":"10.3892","volume":"34","author":[{"given":"MING-SZU","family":"HUNG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-CHUAN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIANG","family":"YOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVID M.","family":"JABLONS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YA-CHIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN-HUA","family":"MAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHIDONG","family":"XU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MENG-JER","family":"HSIEH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YU-CHING","family":"LIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHENG-TA","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIH-TUNG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YING-HUANG","family":"TSAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"key":"key20180107212551_b1-or-34-06-3187","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","article-title":"American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer","volume":"27","author":"Azzoli","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107212551_b2-or-34-06-3187","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180107212551_b3-or-34-06-3187","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1158\/0008-5472.CAN-06-4672","article-title":"Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34","volume":"67","author":"Abba","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107212551_b4-or-34-06-3187","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/bcr2456","article-title":"Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes","volume":"11","author":"Melchor","year":"2009","journal-title":"Breast Cancer Res"},{"key":"key20180107212551_b5-or-34-06-3187","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1582-4934.2009.00971.x","article-title":"Cul4A is an oncogene in malignant pleural mesothelioma","volume":"15","author":"Hung","year":"2011","journal-title":"J Cell Mol Med"},{"key":"key20180107212551_b6-or-34-06-3187","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1053\/jhep.2002.33683","article-title":"TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas","volume":"35","author":"Yasui","year":"2002","journal-title":"Hepatology"},{"key":"key20180107212551_b7-or-34-06-3187","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1158\/0008-5472.CAN-04-2598","article-title":"Cul4A physically associates with MDM2 and participates in the proteolysis of p53","volume":"64","author":"Nag","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107212551_b8-or-34-06-3187","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/onc.2008.44","article-title":"VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation","volume":"27","author":"Huang","year":"2008","journal-title":"Oncogene"},{"key":"key20180107212551_b9-or-34-06-3187","first-page":"289","article-title":"Molecular cloning and expression analysis of evolutionarily conserved stathmin from Gekko japonicus spinal cord","volume":"46","author":"Jiang","year":"2009","journal-title":"Indian J Biochem Biophys"},{"key":"key20180107212551_b10-or-34-06-3187","doi-asserted-by":"crossref","first-page":"29045","DOI":"10.1074\/jbc.M806045200","article-title":"CDK inhibitor p21 is degraded by a PCNA coupled Cul4 DDB1Cdt2 pathway during S phase and after UV irradiation","volume":"43","author":"Nishitani","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180107212551_b11-or-34-06-3187","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/dvg.20708","article-title":"Transgenic mice for cre-inducible overexpression of the Cul4A gene","volume":"49","author":"Li","year":"2011","journal-title":"Genesis"},{"key":"key20180107212551_b12-or-34-06-3187","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1101\/gad.1692808","article-title":"A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors","volume":"22","author":"Miranda-Carboni","year":"2008","journal-title":"Genes Dev"},{"key":"key20180107212551_b13-or-34-06-3187","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4352","article-title":"Lung tumourigenesis in a conditional Cul4A transgenic mouse model","volume":"233","author":"Yang","year":"2014","journal-title":"J Pathol"},{"key":"key20180107212551_b14-or-34-06-3187","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1074\/jbc.M002752200","article-title":"Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3","volume":"275","author":"Kim","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107212551_b15-or-34-06-3187","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mc.20167","article-title":"Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells","volume":"45","author":"Zhao","year":"2006","journal-title":"Mol Carcinog"},{"key":"key20180107212551_b16-or-34-06-3187","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1038\/sj.onc.1205891","article-title":"Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells","volume":"21","author":"Zhao","year":"2002","journal-title":"Oncogene"},{"key":"key20180107212551_b17-or-34-06-3187","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1476-4598-9-130","article-title":"TGFBI expression is associated with a better response to chemotherapy in NSCLC","volume":"9","author":"Irigoyen","year":"2010","journal-title":"Mol Cancer"},{"key":"key20180107212551_b18-or-34-06-3187","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1074\/jbc.M110.186494","article-title":"Cullin-4A DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis","volume":"286","author":"Jiang","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107212551_b19-or-34-06-3187","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1128\/MCB.26.7.2531-2539.2006","article-title":"Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome","volume":"26","author":"Bondar","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20180107212551_b20-or-34-06-3187","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1074\/jbc.M511834200","article-title":"Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC","volume":"281","author":"El-Mahdy","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107212551_b21-or-34-06-3187","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/molecules19010159","article-title":"Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cells","volume":"19","author":"Wang","year":"2013","journal-title":"Molecules"},{"key":"key20180107212551_b22-or-34-06-3187","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4149\/neo_2012_038","article-title":"Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and\/or metastatic pancreatic carcinoma: A retrospective analysis of multicenter study","volume":"59","author":"Inal","year":"2012","journal-title":"Neoplasma"},{"key":"key20180107212551_b23-or-34-06-3187","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2006.01.006","article-title":"Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial","volume":"52","author":"Brodowicz","year":"2006","journal-title":"Lung Cancer"},{"key":"key20180107212551_b24-or-34-06-3187","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-5002(99)00098-7","article-title":"Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: A multicenter phase II study","volume":"27","author":"Ricci","year":"2000","journal-title":"Lung Cancer"},{"key":"key20180107212551_b25-or-34-06-3187","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: A potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat Chem Biol"},{"key":"key20180107212551_b26-or-34-06-3187","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymthe.2004.05.006","article-title":"Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo","volume":"10","author":"Uchida","year":"2004","journal-title":"Mol Ther"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4324\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:26:01Z","timestamp":1515360361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,10,2]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.3892\/or.2015.4324"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4324","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]}}}